These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4276353)

  • 1. [Amantadine in the treatment of Parkinson's disease].
    Penders C
    Rev Med Liege; 1972 Dec; 27(23):835-7. PubMed ID: 4276353
    [No Abstract]   [Full Text] [Related]  

  • 2. Visual hallucinations and delirium during treatment with amantadine (Symmetrel).
    Postma JU; Van Tilburg W
    J Am Geriatr Soc; 1975 May; 23(5):212-5. PubMed ID: 123540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial of amantadine in Parkinson's disease.
    Campbell AM; Williams MJ
    Br J Clin Pract; 1972 Jan; 26(1):19-22. PubMed ID: 4554563
    [No Abstract]   [Full Text] [Related]  

  • 4. [Amantadine treatment in parkinsonism].
    Holmsen R
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2118-9. PubMed ID: 4773984
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of Parkinson's disease with amantadine].
    Sigwald J; Raymondeaud C; Grégoire J
    Therapeutique; 1972 Nov; 48(9):555-60. PubMed ID: 4568230
    [No Abstract]   [Full Text] [Related]  

  • 6. [Amantadine in the treatment of Parkinson's disease].
    Giombini S; Solero CL; Bazzan A; Ferrari P; Robotti E
    Fracastoro; 1970; 63(6):869-81. PubMed ID: 5519639
    [No Abstract]   [Full Text] [Related]  

  • 7. An artist's view of drug-induced hallucinosis.
    Ebersbach G
    Mov Disord; 2003 Jul; 18(7):833-4. PubMed ID: 12815666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease and amantadine hydrochloride.
    JAMA; 1969 May; 208(7):1180-1. PubMed ID: 5818720
    [No Abstract]   [Full Text] [Related]  

  • 9. Amantadine in the treatment of Parkinson's disease.
    Schwab RS; England AC; Poskanzer DC; Young RR
    JAMA; 1969 May; 208(7):1168-70. PubMed ID: 5818715
    [No Abstract]   [Full Text] [Related]  

  • 10. Transient amantadine-induced musical hallucinations in a patient with Parkinson's disease.
    Gondim Fde A; Costa HA; Taunay TC; de Oliveira GR; Ferreira JM; Rola FH
    Mov Disord; 2010 Jul; 25(10):1505-6. PubMed ID: 20629118
    [No Abstract]   [Full Text] [Related]  

  • 11. Amantadine therapy in parkinsonism.
    Forssman B; Kihlstrand S; Larsson LE
    Acta Neurol Scand; 1972; 48(1):1-18. PubMed ID: 4553409
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
    Hacohen H; Gurtner B
    Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377
    [No Abstract]   [Full Text] [Related]  

  • 13. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
    Schwab RS; England AC
    Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
    [No Abstract]   [Full Text] [Related]  

  • 14. Amantadine-HCl in the treatment of Parkinson's disease: a controlled trial.
    MacFadyen DJ; Picton TW; Zeldowicz L; McGeer PL
    J Clin Pharmacol New Drugs; 1972 Jul; 12(7):274-9. PubMed ID: 4483534
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adamantylamine sulfate--a drug for treatment of Parkinson's disease with a new working principle].
    Fünfgeld EW
    Med Klin; 1970 Sep; 65(39):1703-6. PubMed ID: 5474341
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychoactive properties of amantadine.
    Wilcox J
    J Psychoactive Drugs; 1985; 17(1):51-3. PubMed ID: 3981306
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
    Gerstenbrand F; Grünberger J; Oberhummer I
    Wien Med Wochenschr; 1971 May; 121(19):390-7. PubMed ID: 5559920
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
    Gerstenbrand F; Grünberger J; Oberhummer I
    HNO; 1970 Nov; 18(11):390-7. PubMed ID: 5512006
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma amantadine concentrations in patients with Parkinson's disease.
    Nishikawa N; Nagai M; Moritoyo T; Yabe H; Nomoto M
    Parkinsonism Relat Disord; 2009 Jun; 15(5):351-3. PubMed ID: 18823813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amantadine in Parkinson's disease.
    Lancet; 1969 Aug; 2(7616):364. PubMed ID: 4183981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.